COMPOSITION:
Each film coated tablet contains:
Dydrogesterone (micronized) ———– 10 mg
MECHANISM OF ACTION:
Dydrogesterone is an orally-active progestogen which produces a complete secretory endometrium in an estrogen-primed uterus thereby providing protection against the increased risk for endometrium hyperplasia and/or carcinogenesis induced by estrogens. It is indicated in all cases of endogenous progesterone deficiency. Dydrogesterone has no estrogenic, no androgenic, no thermogenic, no anabolic and no corticoid activity.
INDICATION:
Progesterone deficiencies: Treatment of dysmenorrhea.
Treatment of endometriosis.
Treatment of secondary amenorrhea.
Treatment of irregular cycles.
Treatment of dysfunctional uterine bleeding.
Treatment of pre-menstrual syndrome.
Treatment of threatened miscarriage.
Treatment of habitual miscarriage.
Treatment of infertility due to luteal insufficiency.
Luteal support as part of an Assisted Reproductive Technology (ART) treatment.
Hormone replacement therapy: To counteract the effects of unopposed estrogen on the endometrium in hormone replacement therapy for women with disorders due to natural or surgical induced menopause with an intact uterus.
CONTRAINDICATIONS:
Contraindicated in patients hypersensitive to its ingredients.
DISCLAIMER: All content published online is for informational purposes only. It is not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor with any questions you may have regarding your health, medical condition, or any medicines.